Today I am going to review the chart for CVS health Corporation on a weekly timeframe. CVS seems to be following in 18 to 19 week cycle and we saw the latest cycle low being formed with the candle reflecting 27 Jan 2020.
On 12th Feb 2020, CVS reported earnings that broadly beat the street’s estimates. CVS reported adjusted EPS of $1.73, which beat estimates of $1.68. The company reported revenue of $66.9B, which also beat estimates of $63.97B. The company forecasted annual EPS from $7.04 – $7.17 in 2020, which was in-line with analyst expectations of $7.15
Lets look at what the charts are suggesting.
CVS has started the upward move as suggested with the beginning of the cycle over the last couple of weeks after bottoming out around $ 67.81 levels.
CVS is in a very bullish intermediate-term cycle pattern with negative momentum. Given these conditions, we would expect short-term sell-offs to be limited to the intermediate Fibonacci support zone beginning at 70.58. There is a likelihood the stock tests 79 by May 2020
Price is inching upwards towards 75-76 levels, which is the first zone of resistance. This level is important resisitance as this reflects previous cycle high (failed upward move) witnessed during Nov 2019 to Mid Jan 2020. Also, this level shows confluence with Fib levels.... 0.786 levels and hence may act as short term resistance . Once this is cleared, next resistance at 81 to 82.5 levels. As indicated in the chart, this is also cycle high and the previous peak levels , where prices failed to hold on and got into a major declining phase. These levels were last witnessed in Nov and Dec 2018.
Price should find support around 69 to 71 levels in the short term.
For the bears to regain control and for us to revisit our belief, we will require a daily price close below 66.73
If you like what you see, then please share your comments in the box below and share a thumbs up!
On 12th Feb 2020, CVS reported earnings that broadly beat the street’s estimates. CVS reported adjusted EPS of $1.73, which beat estimates of $1.68. The company reported revenue of $66.9B, which also beat estimates of $63.97B. The company forecasted annual EPS from $7.04 – $7.17 in 2020, which was in-line with analyst expectations of $7.15
Lets look at what the charts are suggesting.
CVS has started the upward move as suggested with the beginning of the cycle over the last couple of weeks after bottoming out around $ 67.81 levels.
CVS is in a very bullish intermediate-term cycle pattern with negative momentum. Given these conditions, we would expect short-term sell-offs to be limited to the intermediate Fibonacci support zone beginning at 70.58. There is a likelihood the stock tests 79 by May 2020
Price is inching upwards towards 75-76 levels, which is the first zone of resistance. This level is important resisitance as this reflects previous cycle high (failed upward move) witnessed during Nov 2019 to Mid Jan 2020. Also, this level shows confluence with Fib levels.... 0.786 levels and hence may act as short term resistance . Once this is cleared, next resistance at 81 to 82.5 levels. As indicated in the chart, this is also cycle high and the previous peak levels , where prices failed to hold on and got into a major declining phase. These levels were last witnessed in Nov and Dec 2018.
Price should find support around 69 to 71 levels in the short term.
For the bears to regain control and for us to revisit our belief, we will require a daily price close below 66.73
If you like what you see, then please share your comments in the box below and share a thumbs up!